Log in to save to my catalogue

Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell...

Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2608081706

Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway

About this item

Full title

Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway

Publisher

United States: Public Library of Science

Journal title

PloS one, 2021-12, Vol.16 (12), p.e0261067-e0261067

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Antifibrotic agent for the treatment of liver fibrosis has not been developed so far. Long term treatment of chronic hepatitis B patients with antiviral drugs tenofovir disoproxil fumarate (TDF) and entecavir (ETV) results in the regression of liver fibrosis, but the underlying mechanism has not been clarified. Therefore, we aimed to investigate th...

Alternative Titles

Full title

Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2608081706

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2608081706

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0261067

How to access this item